fda glp 1 regulations GLP-1 Safety Check 21 CFR 11, 58 -

If you are already dealing with semaglutide bloating or tirzepatide bloating , adding a probiotic that causes bloating may worsen things initially

Addressing obesity : For men with obesity affecting body image or sexual function, evidence-based weight management through dietary modification, physical activity, and behavioural support should be offered

evaluated whether baseline fluid biomarkers and optical coherence tomography (OCT) metrics can predict early disability progression in newly diagnosed relapsing-remitting MS (RRMS)

choosing slower-digested carbs and avoiding sugary drinks that can swing blood glucose

Yazawa R, Ishida M, Balavarca Y, Hennige AM

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging